Purpose: Human osteosarcoma is a genetically heterogeneous bone malignancy with poor prognosis despite the employment of aggressive chemotherapy regimens. Because druggable driver mutations have not been established, dissecting the interactions between osteosarcoma cells and supporting stroma may provide insights into novel therapeutic targets.Experimental Design: By using a bioluminescent orthotopic xenograft mouse model of osteosarcoma, we evaluated the effect of tumor extracellular vesicle (EV)-educated mesenchymal stem cells (TEMSC) on osteosarcoma progression. Characterization and functional studies were designed to assess the mechanisms underlying MSC education. Independent series of tissue specimens were analyzed to corroborate the preclinical findings, and the composition of patient serum EVs was analyzed after isolation with size-exclusion chromatography.Results: We show that EVs secreted by highly malignant osteosarcoma cells selectively incorporate a membrane-associated form of TGFβ, which induces proinflammatory IL6 production by MSCs. TEMSCs promote tumor growth, accompanied with intratumor STAT3 activation and lung metastasis formation, which was not observed with control MSCs. Importantly, intravenous administration of the anti-IL6 receptor antibody tocilizumab abrogated the tumor-promoting effects of TEMSCs. RNA-seq analysis of human osteosarcoma tissues revealed a distinct TGFβ-induced prometastatic gene signature. Tissue microarray immunostaining indicated active STAT3 signaling in human osteosarcoma, consistent with the observations in TEMSC-treated mice. Finally, we isolated pure populations of EVs from serum and demonstrated that circulating levels of EV-associated TGFβ are increased in osteosarcoma patients.Conclusions: Collectively, our findings suggest that TEMSCs promote osteosarcoma progression and provide the basis for testing IL6- and TGFβ-blocking agents as new therapeutic options for osteosarcoma patients.

Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression / Baglio, Sr; Lagerweij, T; Pérez Lanzón, M; Xuan Ho, D; Léveillé, N; Melo, Sa; Cleton-Jansen, Am; Jordanova, Es; Roncuzzi, L; Greco, M; van Eijndhoven, Ma; Grisendi, G; Dominici, M; Bonafede, R; Lougheed, S; de Gruijl, Td; Zini, N; Cervo, S; Steffan, A; Canzonieri, V; Martson, A; Maasalu, K; Koks, S; Wurdinger, T; Baldini, N; Pegtel, Dm.. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - (2017), pp. 3721-3733. [10.1158/1078-0432.CCR-16-2726]

Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression

Grisendi G
Methodology
;
Dominici M
Resources
;
2017

Abstract

Purpose: Human osteosarcoma is a genetically heterogeneous bone malignancy with poor prognosis despite the employment of aggressive chemotherapy regimens. Because druggable driver mutations have not been established, dissecting the interactions between osteosarcoma cells and supporting stroma may provide insights into novel therapeutic targets.Experimental Design: By using a bioluminescent orthotopic xenograft mouse model of osteosarcoma, we evaluated the effect of tumor extracellular vesicle (EV)-educated mesenchymal stem cells (TEMSC) on osteosarcoma progression. Characterization and functional studies were designed to assess the mechanisms underlying MSC education. Independent series of tissue specimens were analyzed to corroborate the preclinical findings, and the composition of patient serum EVs was analyzed after isolation with size-exclusion chromatography.Results: We show that EVs secreted by highly malignant osteosarcoma cells selectively incorporate a membrane-associated form of TGFβ, which induces proinflammatory IL6 production by MSCs. TEMSCs promote tumor growth, accompanied with intratumor STAT3 activation and lung metastasis formation, which was not observed with control MSCs. Importantly, intravenous administration of the anti-IL6 receptor antibody tocilizumab abrogated the tumor-promoting effects of TEMSCs. RNA-seq analysis of human osteosarcoma tissues revealed a distinct TGFβ-induced prometastatic gene signature. Tissue microarray immunostaining indicated active STAT3 signaling in human osteosarcoma, consistent with the observations in TEMSC-treated mice. Finally, we isolated pure populations of EVs from serum and demonstrated that circulating levels of EV-associated TGFβ are increased in osteosarcoma patients.Conclusions: Collectively, our findings suggest that TEMSCs promote osteosarcoma progression and provide the basis for testing IL6- and TGFβ-blocking agents as new therapeutic options for osteosarcoma patients.
2017
4-gen-2017
3721
3733
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression / Baglio, Sr; Lagerweij, T; Pérez Lanzón, M; Xuan Ho, D; Léveillé, N; Melo, Sa; Cleton-Jansen, Am; Jordanova, Es; Roncuzzi, L; Greco, M; van Eijndhoven, Ma; Grisendi, G; Dominici, M; Bonafede, R; Lougheed, S; de Gruijl, Td; Zini, N; Cervo, S; Steffan, A; Canzonieri, V; Martson, A; Maasalu, K; Koks, S; Wurdinger, T; Baldini, N; Pegtel, Dm.. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - (2017), pp. 3721-3733. [10.1158/1078-0432.CCR-16-2726]
Baglio, Sr; Lagerweij, T; Pérez Lanzón, M; Xuan Ho, D; Léveillé, N; Melo, Sa; Cleton-Jansen, Am; Jordanova, Es; Roncuzzi, L; Greco, M; van Eijndhoven, Ma; Grisendi, G; Dominici, M; Bonafede, R; Lougheed, S; de Gruijl, Td; Zini, N; Cervo, S; Steffan, A; Canzonieri, V; Martson, A; Maasalu, K; Koks, S; Wurdinger, T; Baldini, N; Pegtel, Dm.
File in questo prodotto:
File Dimensione Formato  
Baglio R et al. Clin Can Res 2017.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 2.26 MB
Formato Adobe PDF
2.26 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
1078-0432.ccr-16-2726.pdf

Open access

Tipologia: Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione 2.17 MB
Formato Adobe PDF
2.17 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1158174
Citazioni
  • ???jsp.display-item.citation.pmc??? 88
  • Scopus 142
  • ???jsp.display-item.citation.isi??? 139
social impact